How to taper Klonopin (clonazepam)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clonazepam (Klonopin) Tapering Protocol

Clonazepam should be tapered gradually with a reduction of 0.25 mg per week to minimize withdrawal symptoms, with slower tapering for patients on long-term therapy. 1, 2

Understanding Clonazepam Withdrawal Risk

Clonazepam is a high-potency benzodiazepine that can cause significant physical dependence with continued use. Abrupt discontinuation or rapid dosage reduction can precipitate acute withdrawal reactions that may be life-threatening, including seizures 1.

Common withdrawal symptoms include:

  • Anxiety and irritability
  • Tremors/shaking
  • Insomnia and nightmares
  • Nausea/vomiting
  • Excessive sweating
  • Tachycardia/palpitations
  • Headache
  • Muscle aches and weakness

Recommended Tapering Schedule

The optimal tapering schedule depends on the current dose, duration of treatment, and individual factors:

For Standard Tapering (Most Patients):

  • Reduce dose by 0.25 mg per week 2
  • For patients on higher doses (>2 mg/day), consider:
    • Initial reduction of 0.5 mg every 2 weeks until reaching 1 mg/day
    • Then slow to 0.25 mg per week until complete discontinuation 2

For Long-Term Users (>3 years):

  • Consider a slower taper of 5-10% reduction every 2-4 weeks 3
  • Once reaching the smallest available dose (0.125 mg), extend the interval between doses (every other day, then every third day) before stopping completely 3

Managing Withdrawal Symptoms

Adjunctive medications can help manage specific withdrawal symptoms:

  • For anxiety/agitation: Trazodone or mirtazapine 4, 3
  • For insomnia: Low-dose trazodone 4, 3
  • For sympathetic hyperactivity: Clonidine (starting with small doses due to potential hypotension) 4, 3
  • For gastrointestinal symptoms: Loperamide 4, 3
  • For muscle aches/pain: NSAIDs or acetaminophen (not exceeding 3000mg daily) 3

Monitoring During Tapering

  • Schedule frequent follow-ups (at least monthly) during the tapering process 3
  • At each visit, assess for:
    • Withdrawal symptoms severity
    • Changes in mood or anxiety
    • Suicidal thoughts
    • Sleep quality
    • Use of other substances

Important Considerations and Pitfalls

  1. Never discontinue clonazepam abruptly - this can lead to severe withdrawal symptoms including seizures 1

  2. Pause the taper if needed - If withdrawal symptoms become significant, pause the taper or return to the previous dose before proceeding with a slower taper 3

  3. Avoid concurrent opioid tapering - Concomitant use of benzodiazepines and opioids increases risk of respiratory depression and death; tapering both simultaneously requires special caution 1

  4. Be aware of protracted withdrawal - Some patients may experience withdrawal symptoms lasting weeks to more than 12 months after discontinuation 1

  5. Consider cognitive-behavioral therapy - Concurrent CBT increases rates of successful discontinuation and duration of abstinence 4

  6. Recognize high-risk patients - Patients with a history of seizures, alcohol use disorder, or prior difficult benzodiazepine withdrawal may require more gradual tapering and closer monitoring 3

Success Rates

Research shows that with proper tapering protocols, approximately 69% of patients can successfully discontinue clonazepam within 4 months, and another 26% within 7 months 2. The improvement in overall well-being is typically maintained during both the taper and follow-up phases when properly managed.

References

Guideline

Opioid Management and Tapering

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.